Overview
News
Technologies
Salaries
Products
People
Growth
Financials

Overview

FEops is a Belgian medical technology company founded in 2014 and based in Ghent. Its HEARTguide platform simulates structural heart procedures on a patient-specific digital twin before surgery. The technology helps cardiologists plan device sizing and placement.

News

Press release materialise.com 2 years ago
Materialise Expands Cardiovascular Capabilities through FEops Acquisition
Materialise has acquired FEops, a Belgian company that develops AI-driven simulation technology to improve procedure efficiency and clinical outcomes for structural heart interventions.
Read more
Report
News bioworld.com 3 years ago
Feops looks to raise €10m, its Heartguide shown to significantly improve LAAC procedures
Feops NV hopes to raise €10 million (US$10.67 million) in a series C fundraising round that will allow the company to scale up its operations worldwide. This follows the release of a study in JACC: Cardiovascular Interventions which revealed that its clou
Read more
Report
News Cardiac Interventions Today 4 years ago
FEops' HeartGuide Solution Studied in PRECISE-TAVI
December 12, 2022-Belgium-based FEops announced that transcatheter aortic valve implantation (TAVI) procedures planned by using the company&rsqu
Read more
Report
News FinanzNachrichten.de 4 years ago
FEops Secures Additional Capital From the EIC Fund
FEops, a cloud-based digital health player in the structural heart space, announces that it has secured a convertible loan of EUR 3.3m from its current investors and the EIC Fund in preparation of a
Read more
Report
Pro access
Upgrade to see all 14 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.